rs129967
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004380.3(CREBBP):c.4280+42C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0477 in 1,612,982 control chromosomes in the GnomAD database, including 9,585 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.15 ( 4131 hom., cov: 33)
Exomes 𝑓: 0.038 ( 5454 hom. )
Consequence
CREBBP
NM_004380.3 intron
NM_004380.3 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.192
Publications
6 publications found
Genes affected
CREBBP (HGNC:2348): (CREB binding protein) This gene is ubiquitously expressed and is involved in the transcriptional coactivation of many different transcription factors. First isolated as a nuclear protein that binds to cAMP-response element binding protein (CREB), this gene is now known to play critical roles in embryonic development, growth control, and homeostasis by coupling chromatin remodeling to transcription factor recognition. The protein encoded by this gene has intrinsic histone acetyltransferase activity and also acts as a scaffold to stabilize additional protein interactions with the transcription complex. This protein acetylates both histone and non-histone proteins. This protein shares regions of very high sequence similarity with protein p300 in its bromodomain, cysteine-histidine-rich regions, and histone acetyltransferase domain. Mutations in this gene cause Rubinstein-Taybi syndrome (RTS). Chromosomal translocations involving this gene have been associated with acute myeloid leukemia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Feb 2009]
CREBBP Gene-Disease associations (from GenCC):
- Rubinstein-Taybi syndromeInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen, Illumina
- Rubinstein-Taybi syndrome due to CREBBP mutationsInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- Menke-Hennekam syndrome 1Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.97).
BP6
Variant 16-3739536-G-A is Benign according to our data. Variant chr16-3739536-G-A is described in ClinVar as [Benign]. Clinvar id is 1242603.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.423 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CREBBP | NM_004380.3 | c.4280+42C>T | intron_variant | Intron 25 of 30 | ENST00000262367.10 | NP_004371.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.145 AC: 22038AN: 152006Hom.: 4113 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
22038
AN:
152006
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0759 AC: 19019AN: 250528 AF XY: 0.0711 show subpopulations
GnomAD2 exomes
AF:
AC:
19019
AN:
250528
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0376 AC: 54889AN: 1460858Hom.: 5454 Cov.: 31 AF XY: 0.0388 AC XY: 28225AN XY: 726724 show subpopulations
GnomAD4 exome
AF:
AC:
54889
AN:
1460858
Hom.:
Cov.:
31
AF XY:
AC XY:
28225
AN XY:
726724
show subpopulations
African (AFR)
AF:
AC:
15046
AN:
33432
American (AMR)
AF:
AC:
1862
AN:
44660
Ashkenazi Jewish (ASJ)
AF:
AC:
2038
AN:
26124
East Asian (EAS)
AF:
AC:
7640
AN:
39662
South Asian (SAS)
AF:
AC:
10411
AN:
86172
European-Finnish (FIN)
AF:
AC:
221
AN:
53396
Middle Eastern (MID)
AF:
AC:
446
AN:
5654
European-Non Finnish (NFE)
AF:
AC:
13090
AN:
1111406
Other (OTH)
AF:
AC:
4135
AN:
60352
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
2670
5340
8009
10679
13349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.145 AC: 22100AN: 152124Hom.: 4131 Cov.: 33 AF XY: 0.142 AC XY: 10584AN XY: 74378 show subpopulations
GnomAD4 genome
AF:
AC:
22100
AN:
152124
Hom.:
Cov.:
33
AF XY:
AC XY:
10584
AN XY:
74378
show subpopulations
African (AFR)
AF:
AC:
17743
AN:
41438
American (AMR)
AF:
AC:
1111
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
295
AN:
3472
East Asian (EAS)
AF:
AC:
1062
AN:
5180
South Asian (SAS)
AF:
AC:
628
AN:
4814
European-Finnish (FIN)
AF:
AC:
36
AN:
10598
Middle Eastern (MID)
AF:
AC:
18
AN:
294
European-Non Finnish (NFE)
AF:
AC:
875
AN:
68024
Other (OTH)
AF:
AC:
264
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
701
1403
2104
2806
3507
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
638
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.